Results 31 to 40 of about 337,094 (289)

Eccentric strength and endurance in patients with unilateral intermittent claudication

open access: yesClinics, 2009
OBJECTIVE: To analyze concentric and eccentric strength and endurance in patients with unilateral intermittent claudication. INTRODUCTION: Basic motor tasks are composed of concentric, isometric, and eccentric actions, which are related and contribute to
Márcio Basyches   +5 more
doaj   +1 more source

Cilostazol for intermittent claudication [PDF]

open access: yesCochrane Database of Systematic Reviews, 2014
Peripheral arterial disease (PAD) affects between 4% and 12% of people aged 55 to 70 years, and 20% of people over 70 years. A common complaint is intermittent claudication (exercise-induced lower limb pain relieved by rest). These patients have a three- to six-fold increase in cardiovascular mortality.
Brown, Tamara   +5 more
openaire   +6 more sources

Silence of the limbs: pharmacological symptomatic treatment of intermittent claudication [PDF]

open access: yes, 2010
Several oral "vasoactive" drugs claim to increase walking capacity in patients with intermittent claudication (IC). Naftidrofuryl, cilostazol, buflomedil, and pentoxifylline are the most studied molecules.
De Backer, Gui   +4 more
core   +1 more source

Increasing walking in patients with intermittent claudication: Protocol for a randomised controlled trial

open access: yesBMC Cardiovascular Disorders, 2010
Background People with intermittent claudication are at increased risk of death from heart attack and stroke compared to matched controls. Surgery for intermittent claudication is for symptom management and does not reduce the risk of cardiovascular ...
O'Carroll Ronan E   +3 more
doaj   +1 more source

Living a burdensome and demanding life: a qualitative systematic review of the patients experiences of peripheral arterial disease [PDF]

open access: yes, 2018
BackgroundPeripheral arterial disease (PAD) has a significant negative impact on the quality of life of individuals. Understanding the experiences of people living with PAD will be useful in developing comprehensive patient-centred secondary prevention ...
Abaraogu, Ukachukwu Okoroafor   +3 more
core   +2 more sources

Peripheral Artery Disease Accompanied by Intermittent Claudication in Rural Areas of Sikka Regency – A Cross Sectional Study with Pulse Palpation Methods and Its Risk Factors

open access: yesJurnal Penyakit Dalam Indonesia, 2017
Introduction. There are few studies regarding peripheral artery disease (PAD by intermittent claudication) on adults in Indonesia, including its risk factors.This study aims to determine relationship and comparison of PAD accompanied by intermittent ...
Naldo Sofian   +2 more
doaj   +1 more source

Transcutaneous calf-muscle electro-stimulation : a prospective treatment for diabetic claudicants? [PDF]

open access: yes, 2016
Background: First-line therapy for claudicants with diabetes include supervised exercise programmes to improve walking distance. However, exercise comes with a number of barriers and may be contraindicated in certain conditions. The aim of this study was
Ellul, Christian, Gatt, Alfred
core   +1 more source

Functional claudication distance: a reliable and valid measurement to assess functional limitation in patients with intermittent claudication

open access: yesBMC Cardiovascular Disorders, 2009
Background Disease severity and functional impairment in patients with intermittent claudication is usually quantified by the measurement of pain-free walking distance (intermittent claudication distance, ICD) and maximal walking distance (absolute ...
Prins Martin H   +5 more
doaj   +1 more source

Buflomedil for intermittent claudication [PDF]

open access: yes, 2013
Background : Intermittent claudication (IC) is pain caused by chronic occlusive arterial disease, that develops in a limb during exercise and is relieved with rest. Buflomedil is a vasoactive agent used to treat peripheral vascular disease.
De Backer, Tine, Vander Stichele, Robert
core   +2 more sources

Patient Characteristics and Comorbidities Influence Walking Distances in Symptomatic Peripheral Arterial Disease: A Large One-Year Physiotherapy Cohort Study. [PDF]

open access: yesPLoS ONE, 2016
OBJECTIVES:The aim of this study is to investigate the association between age, gender, body-mass index, smoking behavior, orthopedic comorbidity, neurologic comorbidity, cardiac comorbidity, vascular comorbidity, pulmonic comorbidity, internal ...
Sarah Dörenkamp   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy